84 related articles for article (PubMed ID: 27326448)
1. [Prasugrel in clinical practice: Frequently asked questions].
Simşek MA; Değertekin MM
Turk Kardiyol Dern Ars; 2015 Oct; 43 Suppl 2():25-9. PubMed ID: 27326448
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?
Guimarães PO; Tricoci P
Expert Opin Pharmacother; 2015; 16(13):1983-95. PubMed ID: 26224244
[TBL] [Abstract][Full Text] [Related]
3. Current Antiplatelet Agents in Acute Coronary Syndrome.
Sachdeva A
J Assoc Physicians India; 2015 Jan; 63(1):75-6. PubMed ID: 26591137
[No Abstract] [Full Text] [Related]
4. Characterization of platelet aggregation responses in microminipigs: Comparison with miniature pigs and the influence of dual antiplatelet administration of aspirin plus prasugrel.
Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A
Thromb Res; 2015 May; 135(5):933-8. PubMed ID: 25776467
[TBL] [Abstract][Full Text] [Related]
5. Prasugrel for Sickle Cell Vaso-Occlusive Events.
Badawy SM
N Engl J Med; 2016 Jul; 375(2):185. PubMed ID: 27410931
[No Abstract] [Full Text] [Related]
6. Prasugrel for Sickle Cell Vaso-Occlusive Events.
Heeney MM; Hoppe CC; Rees DC
N Engl J Med; 2016 Jul; 375(2):185-6. PubMed ID: 27410930
[No Abstract] [Full Text] [Related]
7. Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties.
De Servi S; Cavallini C; Leonardi S; Ferlini M
Int J Cardiol; 2015 Feb; 181():443-5. PubMed ID: 25590784
[No Abstract] [Full Text] [Related]
8. Prasugrel Versus Clopidogrel: A Comparative Examination of Local Bleeding After Dental Extraction in Patients Receiving Dual Antiplatelet Therapy.
Dézsi BB; Koritsánszky L; Braunitzer G; Hangyási DB; Dézsi CA
J Oral Maxillofac Surg; 2015 Oct; 73(10):1894-900. PubMed ID: 26169482
[TBL] [Abstract][Full Text] [Related]
9. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
10. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
[TBL] [Abstract][Full Text] [Related]
11. The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry.
Orban M; Mayer K; Morath T; Bernlochner I; Hadamitzky M; Braun S; Schulz S; Hoppmann P; Hausleiter J; Tiroch K; Mehilli J; Schunkert H; Massberg S; Laugwitz KL; Sibbing D; Kastrati A
Thromb Res; 2015 Jul; 136(1):87-93. PubMed ID: 25976448
[TBL] [Abstract][Full Text] [Related]
12. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM;
Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792
[TBL] [Abstract][Full Text] [Related]
13. Prasugrel hydrochloride, dronedarone, and saxagliptin hydrochloride.
Hussar DA
J Am Pharm Assoc (2003); 2009; 49(6):832-6. PubMed ID: 19926567
[No Abstract] [Full Text] [Related]
14. Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?
Qutub MA; Chong AY; So DY
Can J Cardiol; 2015 Dec; 31(12):1481-4. PubMed ID: 26243350
[TBL] [Abstract][Full Text] [Related]
15. Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial.
Bakal JA; Roe MT; Ohman EM; Goodman SG; Fox KA; Zheng Y; Westerhout CM; Hochman JS; Lokhnygina Y; Brown EB; Armstrong PW
Eur Heart J; 2015 Feb; 36(6):385-92a. PubMed ID: 25012156
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.
Clemmensen P; Roe MT; Hochman JS; Cyr DD; Neely ML; McGuire DK; Cornel JH; Huber K; Zamoryakhin D; White HD; Armstrong PW; Fox KA; Prabhakaran D; Ohman EM;
Am Heart J; 2015 Oct; 170(4):695-705.e5. PubMed ID: 26386793
[TBL] [Abstract][Full Text] [Related]
17. Redesigning TRACER trial after TRITON.
Serebruany VL
Int J Cardiol; 2015 Oct; 197():44-7. PubMed ID: 26126053
[TBL] [Abstract][Full Text] [Related]
18. [Everything about prasugrel in the management of acute coronary syndrome].
Özdemir HM
Turk Kardiyol Dern Ars; 2015 Oct; 43 Suppl 2():v. PubMed ID: 27326443
[No Abstract] [Full Text] [Related]
19. Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.
Bonhomme F; Bonvini R; Reny JL; Poncet A; Fontana P
Platelets; 2015; 26(4):324-30. PubMed ID: 25905916
[TBL] [Abstract][Full Text] [Related]
20. A new era for antiplatelet therapy in patients with acute coronary syndrome.
Dib C; Hanna EB; Abu-Fadel MS
Am J Med Sci; 2010 Nov; 340(5):407-11. PubMed ID: 20818228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
